Peri-immunotherapy Corticosteroid Exposure is Associated with Worse Survival in Head and Neck Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e35
DOI: 10.1016/j.ijrobp.2026.02.068 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von J.S. Feier und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Feier, J., Mino, A., Trent, M., Abello, E., Haidar, Y., Tjoa, T., & Swanson, M. (2026). Peri-immunotherapy Corticosteroid Exposure is Associated with Worse Survival in Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics, 125(1), e35. https://doi.org/10.1016/j.ijrobp.2026.02.068
Vancouver
Feier J, Mino A, Trent M, Abello E, Haidar Y, Tjoa T, et al. Peri-immunotherapy Corticosteroid Exposure is Associated with Worse Survival in Head and Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e35. doi:10.1016/j.ijrobp.2026.02.068
BibTeX
@article{Feier2026,
author = {Feier, J.S. and Mino, A. and Trent, M.S. and Abello, E.H. and Haidar, Y. and Tjoa, T. and Swanson, M.S.},
title = {Peri-immunotherapy Corticosteroid Exposure is Associated with Worse Survival in Head and Neck Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {1},
pages = {e35},
doi = {10.1016/j.ijrobp.2026.02.068}
}
EUVIMED